Medicxi Ventures Management
Latest statistics and disclosures from Medicxi Ventures Management's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by Medicxi Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Medicxi Ventures Management
Medicxi Ventures Management holds 5 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 65.6 | $287M | 20M | 14.38 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 13.4 | $59M | 2.9M | 20.47 |
|
|
| Phathom Pharmaceuticals (PHAT) | 10.7 | $47M | 7.5M | 6.27 |
|
|
| Rapt Therapeutics (RAPT) | 6.2 | $27M | 22M | 1.22 |
|
|
| Aura Biosciences (AURA) | 4.1 | $18M | 3.0M | 5.86 |
|
Past Filings by Medicxi Ventures Management
SEC 13F filings are viewable for Medicxi Ventures Management going back to 2019
- Medicxi Ventures Management 2025 Q1 filed April 11, 2025
- Medicxi Ventures Management 2024 Q4 filed Jan. 23, 2025
- Medicxi Ventures Management 2024 Q3 filed Oct. 15, 2024
- Medicxi Ventures Management 2024 Q2 filed July 16, 2024
- Medicxi Ventures Management 2024 Q1 filed April 15, 2024
- Medicxi Ventures Management 2023 Q4 filed Feb. 1, 2024
- Medicxi Ventures Management 2023 Q3 filed Oct. 18, 2023
- Medicxi Ventures Management 2023 Q2 filed July 19, 2023
- Medicxi Ventures Management 2023 Q1 filed April 27, 2023
- Medicxi Ventures Management 2022 Q4 filed Jan. 31, 2023
- Medicxi Ventures Management 2022 Q3 filed Oct. 25, 2022
- Medicxi Ventures Management 2022 Q2 filed Aug. 3, 2022
- Medicxi Ventures Management 2022 Q2 restated filed Aug. 3, 2022
- Medicxi Ventures Management 2022 Q1 filed May 12, 2022
- Medicxi Ventures Management 2021 Q4 filed Feb. 3, 2022
- Medicxi Ventures Management 2021 Q3 filed Nov. 10, 2021